AKRO NASDAQ
Akero Therapeutics, Inc.
1W: +0.3%
1M: +1.1%
3M: +26.4%
1Y: +84.0%
3Y: +20.2%
5Y: +93.0%
$54.65
Last traded 2025-12-09 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-293M
Net Income
-23.4% YoY
$-250M
Free Cash Flow
-17.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-34.5%
ROA-32.1%
ROIC-118.0%
Valuation
P/E-19.9
P/B4.7
EV/EBITDA-11.0
Leverage
Debt/Equity0.00
Current Ratio15.83
Interest Cov.-62.4x
Quality Scores
Piotroski F2/9
Altman Z47.17
Beneish M0.00